Cargando…

Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy

Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Mark, Fritz, Stephanie, Hake, Daniel, Son, Michael, Greve, Sarah, Jbara, Manar, Chitta, Swetha, Fritz, Braxton, Miller, Adam, Bader, Mary K, McCollester, Jonathon, Binz, Sophia, Liew-Spilger, Alyson, Thomas, Scott, Crepinsek, Anton, Shariff, Faisal, Ploplis, Victoria, Castellino, Francis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374842/
https://www.ncbi.nlm.nih.gov/pubmed/26960340
http://dx.doi.org/10.2174/1389450117666160310153211
_version_ 1782518963896320000
author Walsh, Mark
Fritz, Stephanie
Hake, Daniel
Son, Michael
Greve, Sarah
Jbara, Manar
Chitta, Swetha
Fritz, Braxton
Miller, Adam
Bader, Mary K
McCollester, Jonathon
Binz, Sophia
Liew-Spilger, Alyson
Thomas, Scott
Crepinsek, Anton
Shariff, Faisal
Ploplis, Victoria
Castellino, Francis J.
author_facet Walsh, Mark
Fritz, Stephanie
Hake, Daniel
Son, Michael
Greve, Sarah
Jbara, Manar
Chitta, Swetha
Fritz, Braxton
Miller, Adam
Bader, Mary K
McCollester, Jonathon
Binz, Sophia
Liew-Spilger, Alyson
Thomas, Scott
Crepinsek, Anton
Shariff, Faisal
Ploplis, Victoria
Castellino, Francis J.
author_sort Walsh, Mark
collection PubMed
description Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The varying sensitivity and specificity of these CCTs have led trauma coagulation researchers and clinicians to use Viscoelastic Tests (VET) such as Thromboelastography (TEG) to provide Targeted Thromboelastographic Hemostatic and Adjunctive Therapy (TTHAT) in a goal directed fashion to those trauma patients in need of hemostatic resuscitation. This review describes the utility of VETs, in particular, TEG, to provide TTHAT in trauma and acquired non-trauma-induced coagulopathy.
format Online
Article
Text
id pubmed-5374842
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-53748422017-04-12 Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy Walsh, Mark Fritz, Stephanie Hake, Daniel Son, Michael Greve, Sarah Jbara, Manar Chitta, Swetha Fritz, Braxton Miller, Adam Bader, Mary K McCollester, Jonathon Binz, Sophia Liew-Spilger, Alyson Thomas, Scott Crepinsek, Anton Shariff, Faisal Ploplis, Victoria Castellino, Francis J. Curr Drug Targets Article Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The varying sensitivity and specificity of these CCTs have led trauma coagulation researchers and clinicians to use Viscoelastic Tests (VET) such as Thromboelastography (TEG) to provide Targeted Thromboelastographic Hemostatic and Adjunctive Therapy (TTHAT) in a goal directed fashion to those trauma patients in need of hemostatic resuscitation. This review describes the utility of VETs, in particular, TEG, to provide TTHAT in trauma and acquired non-trauma-induced coagulopathy. Bentham Science Publishers 2016-06 2016-06 /pmc/articles/PMC5374842/ /pubmed/26960340 http://dx.doi.org/10.2174/1389450117666160310153211 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Walsh, Mark
Fritz, Stephanie
Hake, Daniel
Son, Michael
Greve, Sarah
Jbara, Manar
Chitta, Swetha
Fritz, Braxton
Miller, Adam
Bader, Mary K
McCollester, Jonathon
Binz, Sophia
Liew-Spilger, Alyson
Thomas, Scott
Crepinsek, Anton
Shariff, Faisal
Ploplis, Victoria
Castellino, Francis J.
Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
title Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
title_full Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
title_fullStr Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
title_full_unstemmed Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
title_short Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
title_sort targeted thromboelastographic (teg) blood component and pharmacologic hemostatic therapy in traumatic and acquired coagulopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374842/
https://www.ncbi.nlm.nih.gov/pubmed/26960340
http://dx.doi.org/10.2174/1389450117666160310153211
work_keys_str_mv AT walshmark targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT fritzstephanie targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT hakedaniel targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT sonmichael targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT grevesarah targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT jbaramanar targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT chittaswetha targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT fritzbraxton targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT milleradam targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT badermaryk targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT mccollesterjonathon targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT binzsophia targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT liewspilgeralyson targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT thomasscott targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT crepinsekanton targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT sharifffaisal targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT ploplisvictoria targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy
AT castellinofrancisj targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy